MRCH
Setback for Novo Nordisk: Alzheimer’s Drug Trials Fall Short, Impacting Weight Loss Innovation
Novo Nordisk recently faced a significant blow when its trials for an older version of its semaglutide drug failed to ... Read more
Metsera Embraces Pfizer’s $10 Billion Offer: An Inside Look at the Latest M&A Showdown
On November 7, 2023, Metsera, a company developing obesity drugs, accepted a $10 billion offer from Pfizer. This move seems ... Read more
Russia Unveils New Nuclear-Powered Burevestnik Cruise Missile: What It Means for Global Security
Moscow has just announced a significant milestone in its military capabilities. On October 21, Russia successfully tested its nuclear-powered cruise ... Read more
